• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Aemetis Inc. (DE) filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    3/16/26 4:18:27 PM ET
    $AMTX
    Major Chemicals
    Industrials
    Get the next $AMTX alert in real time by email
    amtx20260312_8k.htm
    false 0000738214 0000738214 2026-03-10 2026-03-10
     
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): March 10, 2026
     
    Aemetis, Inc.
    Exact name of registrant as specified in its charter
     
    Delaware
    001-36475
    26-1407544
    State or other jurisdiction of incorporation
    Commission File Number
    IRS Employer Identification Number
     
    20400 Stevens Creek Blvd., Suite 700
    Cupertino, CA 95014
    (408) 213-0940
    Registrant's address and telephone number of principal executive office
     
    N/A
    Former name or former address, if changed since last report
     
    Common Stock, par value $0.001
    AMTX
    NASDAQ Global Market
    Title of class of registered securities Trading Symbol Name of exchange on which registered
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
     
    ☐
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter)
     
     
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
     
     

     
     
    Item 4.01 Changes in Registrant’s Certifying Accountant
     
    On March 10, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of Aemetis, Inc. (the “Company”) approved the engagement of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm, beginning with the review of the Company’s financial statements for the quarter ending March 31, 2026, and including the audit of the Company’s consolidated financial statements for the fiscal year ending December 31, 2026. The engagement of KPMG is subject to the execution of an engagement letter.
     
    On March 10, 2026, the Audit Committee also dismissed RSM US LLP (“RSM”) as the Company’s independent registered public accounting firm, effective after the completion of its audit for the fiscal year ended December 31, 2025, and related non-audit services. RSM served as the Company’s independent registered public accounting firm since 2012.
     
    The audit reports of RSM on the Company’s consolidated financial statements for the fiscal years ended December 31, 2025, and December 31, 2024, did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles, except that RSM's report for each of the two fiscal years ended December 31, 2025, and December 31, 2024, contained an explanatory paragraph about the Company's ability to continue as a going concern.
     
    During the Company’s fiscal years ended December 31, 2025, and December 31, 2024, and the subsequent interim period through March 10, 2026, there were no (i) disagreements, as defined in Item 304(a)(1)(iv) of Regulation S‑K and the related instructions to Item 304, with RSM on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures that, if not resolved to the satisfaction of RSM, would have caused RSM to make reference to the subject matter of such disagreements in its reports, or (ii) reportable events as defined in Item 304(a)(1)(v) of Regulation S‑K and the related instructions to Item 304, except for the material weaknesses in internal control over financial reporting as of December 31, 2024, that were previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. The Audit Committee has discussed the subject matter of the material weaknesses with RSM, and the Company has authorized RSM to respond fully to the inquiries of KPMG concerning them.
     
    During the Company’s fiscal years ended December 31, 2025, and December 31, 2024, and the subsequent interim period through March 10, 2026, neither the Company nor anyone acting on its behalf consulted with KPMG regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and either a written report or oral advice was provided to the Company that KPMG concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was the subject of a disagreement or reportable event, as defined in Item 304(a)(1)(iv) and Item 304(a)(1)(v) of Regulation S‑K.
     
    The Company provided RSM with a copy of this Current Report on Form 8‑K (this “Report”) prior to its filing with the Securities and Exchange Commission (the “SEC”) and requested that RSM furnish the Company with a letter addressed to the SEC stating whether it agrees with the statements made by the Company in this Item 4.01 and, if not, stating the respects, if any, in which RSM does not agree with such statements, as required by Item 304(a)(3) of Regulation S‑K. A copy of RSM’s letter is filed as Exhibit 16.1 to this Report.
     
    Item 9.01 Financial Statements and Exhibits.
     
    (d) Exhibits.
     
    Exhibit No.
    Description
    16.1
    Letter from RSM US LLP to the Securities and Exchange Commission dated March 16, 2026.
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document).
     
    SIGNATURE
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
     
      Aemetis, Inc.
       
       March 16, 2026
    /s/ Eric A. McAfee
     
    Eric A. McAfee
     
    Chairman and Chief Executive Officer
     
     
     
     
    Get the next $AMTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMTX

    DatePrice TargetRatingAnalyst
    8/16/2023$2.50 → $10.50Neutral → Buy
    UBS
    2/28/2023$3.00Underweight
    Piper Sandler
    12/14/2022$4.25Neutral
    UBS
    8/9/2022$12.00Buy → Hold
    Truist
    11/22/2021$31.00 → $35.00Outperform
    Credit Suisse
    8/23/2021$40.00 → $31.00Outperform
    Credit Suisse
    7/15/2021$25.00Outperform
    Evercore ISI Group
    More analyst ratings

    $AMTX
    SEC Filings

    View All

    Aemetis Inc. (DE) filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - AEMETIS, INC (0000738214) (Filer)

    3/16/26 4:18:27 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form S-8 filed by Aemetis Inc. (DE)

    S-8 - AEMETIS, INC (0000738214) (Filer)

    3/16/26 8:12:32 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis Inc. (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AEMETIS, INC (0000738214) (Filer)

    3/12/26 8:30:09 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aemetis Reports Fourth Quarter and Full Year 2025 Results as Dairy RNG Platform Scales

    Dairy RNG production increased 61% year over year in Q4 2025; ethanol plant efficiency upgrade expected to increase plant cash flow from operations by approximately $32 million annually Aemetis Biogas segment net income increased to $12.2 million in Q4 2025Aemetis Biogas segment increased annual revenues and production tax credits by 53%Dairy RNG production increased 61% year over year in Q4 2025Aemetis Biogas achieved annual segment net income of $6.9 millionCapital investments increased 28% over the prior year to $26.0 million, supporting dairy RNG expansion and ethanol plant energy efficiency upgradesDairy digester projects generated cash proceeds of $18 million during 2025 from the sale

    3/12/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis to Review Fourth Quarter and Year End 2025 Financial Results on March 12, 2026

    CUPERTINO, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its fourth quarter and year end 2025 earnings report: Date: Thursday, March 12, 2026 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 452750 Live Participant Dial In (International): +1-973-528-0011 entry code 452750 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/53629 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Cal

    3/6/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis India Subsidiary Begins Biodiesel Deliveries Under $24 Million Allocation from OMCs

    CUPERTINO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX), a diversified renewable natural gas and biofuels company, announced that its Universal Biofuels subsidiary in India secured allocations of approximately $24 million for the supply of more than 27 million liters of biodiesel to India's three government-owned Oil Marketing Companies (OMCs) for the period ending March 2026. Additional OMC fuel supply orders are expected throughout the year to support the India government's goal of increasing from a 1% biodiesel blend to a targeted 5%, as stated in the current India National Policy on Biofuels. "Universal Biofuels and other biodiesel producers look forward to c

    2/3/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Simon Timothy Alan was granted 12,000 shares, increasing direct ownership by 30% to 52,632 units (SEC Form 4)

    4 - AEMETIS, INC (0000738214) (Issuer)

    1/28/26 8:08:09 PM ET
    $AMTX
    Major Chemicals
    Industrials

    Director Block John R was granted 12,000 shares, increasing direct ownership by 35% to 46,330 units (SEC Form 4)

    4 - AEMETIS, INC (0000738214) (Issuer)

    1/28/26 8:07:34 PM ET
    $AMTX
    Major Chemicals
    Industrials

    Director Barton Francis P was granted 18,000 shares, increasing direct ownership by 9% to 226,518 units (SEC Form 4)

    4 - AEMETIS, INC (0000738214) (Issuer)

    1/28/26 8:06:59 PM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aemetis upgraded by UBS with a new price target

    UBS upgraded Aemetis from Neutral to Buy and set a new price target of $10.50 from $2.50 previously

    8/16/23 8:55:59 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Piper Sandler initiated coverage on Aemetis with a new price target

    Piper Sandler initiated coverage of Aemetis with a rating of Underweight and set a new price target of $3.00

    2/28/23 6:17:45 AM ET
    $AMTX
    Major Chemicals
    Industrials

    UBS initiated coverage on Aemetis with a new price target

    UBS initiated coverage of Aemetis with a rating of Neutral and set a new price target of $4.25

    12/14/22 7:31:59 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Leadership Updates

    Live Leadership Updates

    View All

    Aemetis Appoints J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary

    CUPERTINO, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, has appointed J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary, effective immediately. Mr. Rockett brings over 28 years of relevant experience to the company. Prior to joining Aemetis, he was Vice President, General Counsel, and Corporate Secretary of InEnTec Inc., a developer of technology and facilities to convert waste into renewable fuels and chemical products. Mr. Rockett was formerly an attorney at the law firm of Pillsbury Winthrop Shaw Pittman L

    8/28/23 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis Appoints Former California Public Utilities Commissioner Timothy Simon to the Aemetis Board of Directors

    CUPERTINO, CA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas (RNG) and renewable fuels company focused on negative carbon intensity products, today announced the appointment of Timothy Alan Simon, Esq., former Commissioner of the California Public Utilities Commission (CPUC), to the Company's Board of Directors, effective October 14.  Mr. Simon was appointed to the CPUC by Governor Arnold Schwarzenegger in February 2007, ending his term in December 2012. During his time as a CPUC commissioner, Mr. Simon served as Chair of the National Association of Regulatory Utility Commissioners ("NARUC") Natural Gas Committee; Chair of the

    10/18/21 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Indonesia Energy Corporation Announces Appointment of Michael L. Peterson to Board of Directors

    Experienced energy industry and finance executive to serve as Chairman of IEC's Audit Committee JAKARTA, INDONESIA AND DANVILLE, CA / ACCESSWIRE / January 25, 2021 / Indonesia Energy Corporation (NYSE American:INDO) ("IEC"), an oil and gas exploration and production company focused on Indonesia, today announced that the company's Board of Directors has appointed Michael L. Peterson to the Board. Mr. Peterson will serve as an independent Board member and will also serve as the Chairman of the Audit Committee of the Board of Directors. Mr. Peterson has over 30 years of experience in executive management positions in all aspects of the energy industry and finance industries, having served as

    1/25/21 9:00:00 AM ET
    $PED
    $MEDS
    $INDO
    Oil & Gas Production
    Energy
    Other Pharmaceuticals
    Health Care

    $AMTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/14/24 4:19:02 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/14/24 2:54:17 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/13/24 6:50:28 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Financials

    Live finance-specific insights

    View All

    Aemetis Reports Fourth Quarter and Full Year 2025 Results as Dairy RNG Platform Scales

    Dairy RNG production increased 61% year over year in Q4 2025; ethanol plant efficiency upgrade expected to increase plant cash flow from operations by approximately $32 million annually Aemetis Biogas segment net income increased to $12.2 million in Q4 2025Aemetis Biogas segment increased annual revenues and production tax credits by 53%Dairy RNG production increased 61% year over year in Q4 2025Aemetis Biogas achieved annual segment net income of $6.9 millionCapital investments increased 28% over the prior year to $26.0 million, supporting dairy RNG expansion and ethanol plant energy efficiency upgradesDairy digester projects generated cash proceeds of $18 million during 2025 from the sale

    3/12/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis to Review Fourth Quarter and Year End 2025 Financial Results on March 12, 2026

    CUPERTINO, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its fourth quarter and year end 2025 earnings report: Date: Thursday, March 12, 2026 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 452750 Live Participant Dial In (International): +1-973-528-0011 entry code 452750 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/53629 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Cal

    3/6/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis to Review Third Quarter 2025 Financial Results on November 6, 2025

    CUPERTINO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its third quarter 2025 earnings report: Date: Thursday, November 6, 2025 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 188767  Live Participant Dial In (International): +1-973-528-0011 entry code 188767 Webcast URL: https://www.webcaster5.com/Webcast/Page/2211/53150 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Calls, along w

    10/31/25 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials